Evidence-based review of the utility of radiation therapy in the treatment of endometrial cancer SB Dewdney†1 & DG Mutch1 Endometrial cancer is the most common cancer of the female genital tract in the USA and usually presents at an early stage. Most women are cured with surgery, however, some patients may require adjuvant therapy including radiation and/or chemotherapy. Risk factors determine the need for adjuvant treatment and, based on these risk factors, patients are categorized as being at low, intermediate or high risk for recurrence. In this article we will review the best level of evidence available for the use of radiation therapy within each risk stratum. The most controversy and debate is associated with patients stratified t...
Endometrial cancer (EC) is the most common gynaecological cancer in developed countries. Standard tr...
BACKGROUND AND PURPOSE: Radiotherapy is a good option for inoperable and frail patients diagnosed wi...
Objective: The Post-Operative Radiation Therapy in Endometrial Carcinoma (PORTEC)-4a trial is a rand...
Introduction: Although the majority of women with endometrial cancer have a favorable prognosis due ...
Endometrial cancer is the most common gynecological cancer in western countries and endometrial canc...
Copyright © 2013 Helen E. Dinkelspiel et al. This is an open access article distributed under the Cr...
The role of adjuvant radiotherapy in stage I endometrial cancer following surgery remains unclear. T...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Background The role of adjuvant radiotherapy in stage I endometrial cancer has changed in recent yea...
Objectives: The aim of this study was to examine the patterns of failure following adjuvant radiothe...
Endometrial cancer is a relatively common gynecological cancer which is increasing in incidence. Sur...
Radiotherapy is a good option for inoperable and frail patients diagnosed with endometrial cancer. B...
SummaryObjectiveTo better understand the potential risks and benefits of adjuvant radiotherapy in pa...
INTRODUCTION: To define indications for adjuvant radiotherapy in patients with endometrial cancer, t...
Background: Up to now, the role of adjuvant radiation therapy and the extent of lymph node dissectio...
Endometrial cancer (EC) is the most common gynaecological cancer in developed countries. Standard tr...
BACKGROUND AND PURPOSE: Radiotherapy is a good option for inoperable and frail patients diagnosed wi...
Objective: The Post-Operative Radiation Therapy in Endometrial Carcinoma (PORTEC)-4a trial is a rand...
Introduction: Although the majority of women with endometrial cancer have a favorable prognosis due ...
Endometrial cancer is the most common gynecological cancer in western countries and endometrial canc...
Copyright © 2013 Helen E. Dinkelspiel et al. This is an open access article distributed under the Cr...
The role of adjuvant radiotherapy in stage I endometrial cancer following surgery remains unclear. T...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Background The role of adjuvant radiotherapy in stage I endometrial cancer has changed in recent yea...
Objectives: The aim of this study was to examine the patterns of failure following adjuvant radiothe...
Endometrial cancer is a relatively common gynecological cancer which is increasing in incidence. Sur...
Radiotherapy is a good option for inoperable and frail patients diagnosed with endometrial cancer. B...
SummaryObjectiveTo better understand the potential risks and benefits of adjuvant radiotherapy in pa...
INTRODUCTION: To define indications for adjuvant radiotherapy in patients with endometrial cancer, t...
Background: Up to now, the role of adjuvant radiation therapy and the extent of lymph node dissectio...
Endometrial cancer (EC) is the most common gynaecological cancer in developed countries. Standard tr...
BACKGROUND AND PURPOSE: Radiotherapy is a good option for inoperable and frail patients diagnosed wi...
Objective: The Post-Operative Radiation Therapy in Endometrial Carcinoma (PORTEC)-4a trial is a rand...